RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 56 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 3 | -99.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 459 | -83.7% | 0.00% | – |
| Q1 2022 | $16,000 | -51.5% | 2,822 | -16.6% | 0.00% | – |
| Q4 2021 | $33,000 | -56.0% | 3,385 | +9.7% | 0.00% | – |
| Q2 2021 | $75,000 | -9.6% | 3,087 | -0.9% | 0.00% | – |
| Q1 2021 | $83,000 | -49.4% | 3,116 | -85.5% | 0.00% | – |
| Q4 2020 | $164,000 | +4000.0% | 21,536 | +2976.6% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 700 | -14.7% | 0.00% | – |
| Q1 2020 | $4,000 | -87.9% | 821 | -76.1% | 0.00% | – |
| Q4 2019 | $33,000 | +725.0% | 3,430 | +518.0% | 0.00% | – |
| Q3 2019 | $4,000 | +100.0% | 555 | +270.0% | 0.00% | – |
| Q4 2018 | $2,000 | -81.8% | 150 | -66.0% | 0.00% | – |
| Q3 2018 | $11,000 | – | 441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |